日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2

克唑替尼治疗MET扩增或14号外显子缺失的肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)C1和C2子方案的结果

Coleman, Niamh; Wei, Zihan; Iafrate, A John; Zwiebel, James A; Sharon, Elad; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Williams, Travis; Croley, Jessica J; Onitilo, Adedayo A; Tricoli, James V; Cheng, Ju; Karlovich, Chris; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay; O'Dwyer, Peter J; Hong, David S; Chen, Alice P; Flaherty, Keith T

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF(V600E) Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H

达拉非尼和曲美替尼治疗BRAF(V600E)突变肿瘤患者的II期研究:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案H的最新结果

Salama, April K S; Wang, Victoria; Macrae, Erin R; Park, Jong-In; Chen, Helen X; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David; Williams, P Mickey; Hamilton, Stanley R; Armstrong, Deborah K; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E

拉罗替尼治疗NTRK融合肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案EAY131-Z1E的结果

Akhave, Neal; Song, Zihe; Hong, David S; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials

双向紫杉醇联合卡培他滨或尼洛替尼治疗腹膜癌的疗效:两项II期临床试验的单中心分析

Gallanis, Amber F; Perati, Shruthi R; Canady, Stephanie N; Epstein, Monica; Moore, Nancy; Satterwhite, Audra A; Mallory, Yvonne; Ahn, Diane; Bowden, Cassidy; Figueiroa, Silvia; Lee, John J; de Souza, Andre; Shin, Sarah; Ahmed, Jibran; Sullivan, Molly A; Joyce, Stacy R; Hernandez, Jonathan M; Chen, Alice; Alewine, Christine C; Davis, Jeremy L; Blakely, Andrew M

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.

硼替佐米和氯法拉滨联合治疗难治性肿瘤成人患者的 I 期试验。

Ahmed Jibran, DeSouza Andre, Kummar Shivaani, Rubinstein Lawrence, O'Sullivan-Coyne Geraldine, Govindharajulu Jeevan, Herrick William, Ferry-Galow Kate, Li Li, Wilsker Deborah F, Hogu Murielle, Piekarz Richard, Meehan Robert, Salkeni Mohamad Adham, Shin Sarah, Miller Brandon, Zlott Jennifer, Juwara Lamin, Gray Karen, Kuhlmann Laura, Srivastava Apurva, Parchment Ralph E, Doroshow James H, Takebe Naoko, Chen Alice P

Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study

selumetinib治疗1型神经纤维瘤病合并症状性、不可手术切除的丛状神经纤维瘤成人患者的疗效和安全性(KOMET):一项多中心、国际性、随机、安慰剂对照、平行、双盲3期研究

Chen, Alice P; Coyne, Geraldine O'Sullivan; Wolters, Pamela L; Martin, Staci; Farschtschi, Said; Blanco, Ignacio; Chen, Zhongping; Darrigo, Luiz Guilherme Jr; Eoli, Marica; Whittle, James R; Nishida, Yoshihiro; Lamarca, Rosa; de la Rosa Rodriguez, Randolph; Adeyemi, Ayo; Herrero, Idoia; Llorente, Nereida; Diede, Scott J; Dombi, Eva; Wolkenstein, Pierre

Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial

Selumetinib治疗成人NF1合并不可手术的丛状神经纤维瘤:一项II期试验

Gross, Andrea M; O'Sullivan Coyne, Geraldine; Dombi, Eva; Tibery, Cecilia; Herrick, William G; Martin, Staci; Angus, Steven P; Shern, Jack F; Rhodes, Steven D; Foster, Jared C; Rubinstein, Larry V; Baldwin, Andrea; Davis, Christopher; Dixon, Shelley A H; Fagan, Margaret; Ong, Mary Jane; Wolters, Pamela L; Tamula, Mary Anne; Reid, Olivia; Sankaran, Hari; Fang, Fang; Govindharajulu, Jeevan Prasaad; Browne, Alice T; Kaplan, Rosandra N; Heisey, Kara; On, Thomas J; Xuei, Xiaoling; Zhang, Xiyuan; Johnson, Barry C; Parchment, Ralph E; Clapp, D Wade; Srivastava, Apurva K; Doroshow, James H; Chen, Alice P; Widemann, Brigitte C

Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer

肿瘤临床试验中的心血管安全性:JACC:心血管肿瘤学入门

Bonaca, Marc P; Lang, Ninian N; Chen, Alice; Amiri-Kordestani, Laleh; Lipka, Leslie; Zwiewka, Michal; Strnadova, Colette; Klaar, Sigrid; Dent, Susan; Janicijevic, Tijana Krnjeta; Herrmann, Joerg; Barac, Ana; de Boer, Rudolf A; Deswal, Anita; Schou, Morten; Neilan, Tomas G; van der Meer, Peter; Moslehi, Javid; Kondapalli, Lavanya; Ky, Bonnie; Fernandez, Teresa Lopez; Cornell, R Frank; Flaig, Thomas W; Hsia, Judith; Sharon, Elad; de Azambuja, Evandro; Seltzer, Jonathan; Januzzi, James L; Petrie, Mark C

Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers

一项评估重组白细胞介素-15联合纳武利尤单抗和伊匹木单抗治疗难治性癌症患者的安全性、初步疗效和药效学的I期研究

Ahmed, Jibran; O'Sullivan Coyne, Geraldine; Rubinstein, Larry V; Shin, Sarah J; Takebe, Naoko; Bruns, Ashley; Augustine, Brooke; Mukherjee, Jessica; Ma, Ning; Fino, Kristin; Fung, King Leung; Ferry-Galow, Katherine V; Johnson, Barry C; Parchment, Ralph E; Streicher, Howard; Doroshow, James H; Chen, Alice P

A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors

尼洛替尼联合紫杉醇治疗晚期实体瘤患者的I期研究

Shin, Sarah J; O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Miller, Sarah B; Johnson, Barry C; Anderson, Larry; Rubinstein, Larry; Miller, Brandon; Wilsker, Deborah F; Ferry-Galow, Katherine V; Piekarz, Richard; Zlott, Jennifer; Hogu, Murielle; Juwara, Lamin; Krushkal, Julia; Konaté, Mariam; Palmisano, Alida; Zhao, Yingdong; Collins, Jerry; Parchment, Ralph E; Doroshow, James H; Chen, Alice P